Cargando…
Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer
Efficient inhibition of tumor metastasis after resection of primary tumors is critical for cancer therapy. We have recently shown that Cyr61 promotes growth of pancreatic ductal adenocarcinoma (PDAC) through PI3k/Akt signaling-enhanced nuclear exclusion of p27. Here, we report that administration of...
Autores principales: | Shi, Weidong, Zhang, Chenyue, Chen, Zhen, Chen, Hao, Liu, Luming, Meng, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341970/ https://www.ncbi.nlm.nih.gov/pubmed/27705906 http://dx.doi.org/10.18632/oncotarget.12248 |
Ejemplares similares
-
Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
por: Banerjee, Snigdha, et al.
Publicado: (2019) -
Aberrant activation of CYR61 enhancers in colorectal cancer development
por: Xie, Lingzhu, et al.
Publicado: (2019) -
Cyr61 Expression is associated with prognosis in patients with colorectal cancer
por: Jeong, Dongjun, et al.
Publicado: (2014) -
Cyr61: a potential therapeutic target for prostate cancer
por: Lin, Chang-Ming, et al.
Publicado: (2014) -
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
por: Sun, Z-J, et al.
Publicado: (2008)